285 results on '"Rawi, Reda"'
Search Results
2. Cholesterol reduction by immunization with a PCSK9 mimic
3. Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase
4. Cryo-EM structures of prefusion SIV envelope trimer
5. Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases
6. HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide
7. Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design
8. Vaccine elicitation and structural basis for antibody protection against alphaviruses
9. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses
10. A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination
11. Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody
12. Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies
13. Rapid Emergence and Evolution of SARS-CoV-2 Variants in Advanced HIV Infection
14. Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies
15. Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces
16. Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes
17. Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5.
18. Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain
19. Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
20. Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization
21. Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency
22. Accurate Prediction for Antibody Resistance of Clinical HIV-1 Isolates
23. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
24. Antibodies as drugs—a Keystone Symposia report
25. Computational Neuro-Modeling of Visual Memory: Multimodal Imaging and Analysis
26. Improvement of antibody functionality by structure-guided paratope engraftment
27. Correction to: Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank Project
28. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
29. Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite
30. Highly protective antimalarial antibodies via precision library generation and yeast display screening
31. Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site
32. C3-Symmetric Aromatic Core of Griffithsin Is Essential for Potent Anti-HIV Activity
33. Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank Project
34. Structural basis for llama nanobody recognition and neutralization of HIV-1
35. In Silico Improvement of Highly Protective Anti-Malarial Antibodies
36. Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2
37. Vaccine-elicitation of cross-group neutralizing protective antibodies to influenza A viruses
38. Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies
39. GLYCO: a tool to quantify glycan shielding of glycosylated proteins
40. Blocking α 4 β 7 integrin delays viral rebound in SHIV SF162P3 -infected macaques treated with anti-HIV broadly neutralizing antibodies
41. Augmenting Neutralization breadth against Diverse HIV-1 by increasing the Ab-Ag interface on V2
42. Inference of global HIV-1 sequence patterns and preliminary feature analysis
43. Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography
44. Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses
45. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
46. C3‑Symmetric Aromatic Core of Griffithsin Is Essential for Potent Anti-HIV Activity.
47. Computational Neuro-Modeling of Visual Memory: Multimodal Imaging and Analysis
48. Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains
49. Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent Elicitation
50. Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.